Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-988]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: Purisys, LLC. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to 
                        **SUPPLEMENTAL INFORMATION**
                         listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 6, 2022. Such persons may also file a written request for a hearing on the application on or before June 6, 2022.
 ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to 
                        *https://www.regulations.gov*
                         and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on 
                        *https://www.regulations.gov.*
                         If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on January 21, 2022, 1550 Olympic Drive, Athens, Georgia 30601-1602, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Controlled substance
Drug code
ScheduleCathinone
1235
IGamma Hydroxybutyric Acid
2010
ILysergic acid diethylamide
7315
IMarihuana Extract
7350
IMarihuana
7360
ITetrahydrocannabinols
7370
I2,5-Dimethoxyamphetamine
7396
I3,4-Methylenedioxy 
                              amphetamine.
7400
I5-Methoxy-3,4-methylenedioxy amphetamine
7401
I3,4-Methylenedioxy 
                              methamphetamine.
7405
I5-Methoxy-N-N-dimethyl 
                              tryptamine.
7431
IDiethyltryptamine
7434
IDimethyltryptamine
7435
IPsilocybin
7437
IPsilocyn
7438
ICodeine-N-oxide
9053
IDihydromorphine
9145
IHydromorphinol
9301
IMorphine-N-oxide
9307
INormorphine
9313
INorlevorphanol
9634
ICodeine
9050
IIDihydrocodeine
9120
IIOxycodone
9143
IIHydromorphone
9150
IIHydrocodone
9193
IILevorphanol
9220
IIMorphine
9300
IIOripavine
9330
IIThebaine
9333
IIOpium tincture
9630
IIOpium, powdered
9639
IIOpium, granulated
9640
IIOxymorphone
9652
IINoroxymorphone
9668
IIAlfentanil
9737
IISufentanil
9740
IICarfentanil
9743
IITapentadol
9780
IIFentanyl
9801
II
 The company plans to bulk manufacture the listed controlled substances for internal use intermediates or for sale to its customers. The company plans to manufacture the above-listed controlled substances as clinical trial and starting materials to make compounds for distribution to its customers. No other activities for these drug codes are authorized for this registration. Matthew J. Strait, Deputy Assistant Administrator.


[FR Doc. 2022-07368 Filed 4-6-22; 8:45 am] BILLING CODE P